Oxford, UK [Marlborough, MA]; 25 June 2010 - Oxford Immunotec Inc, announces the release of new
Centers for Disease Control and Prevention (CDC) guidelines for using interferon gamma release
assays (IGRA) to detect Mycobacterium tuberculosis infection. For the first time, the CDC make
specific recommendations for which an IGRA is preferred over use of the 100+ year-old tuberculin skin
test (TST), including persons who have received the BCG vaccination, and for persons unlikely to
return for the required reading of results needed to complete the test.

Ensure Safer Transportation of Biological Samples with New Sterilin 95kPa Compliant Containers

For 50 years Sterilin has set world standards for quality, reliability and user safety. They are leading the way forward again, with the introduction of 95kPa validated containers for the safe and reliable transportation of biological samples.
 

Crumlin, UK, June 2010

Randox Laboratories is one of the largest manufacturers of quality control sera in the world. The Acusera range of quality controls currently covers over 290 parameters and is set to expand with the introduction of several new quality controls. 

Screening for Drug Drivers

The Home Office Scientific Development Branch (HOSDB) and the Technology Strategy Board are launching a SBRI competition to fund development work on an oral fluid screening device to aid the detection of drug drivers by the police.
 

Siemens introduces CardioPhase hsCRP to ADVIA Chemistry systems

Consolidating specialist cardiac testing onto routine high throughput systems

Siemens Healthcare Diagnostics has introduced ADVIA® Chemistry CardioPhase™ hsCRP assay, consolidating specialist cardiac testing onto routine high throughput analysis.  The assay is qualified for independent cardiac risk assessment as well as cardiac risk stratification.  The results exhibit excellent correlation and similar performance to the industry gold standard method which is the Siemens BNII™ Nephelometer.

Half a million people in North Bristol, South Gloucestershire and North Somerset to benefit from faster lab results

Southmead Hospital is the second site in the world to go live with the cobas® 8000

Roche is delighted to announce that Southmead Hospital, part of the North Bristol NHS Trust, is the first site in the UK, and only the second worldwide, to go live with  Roche’s brand new cobas® 8000 series high throughput modular analyser.  Located in the hospital’s new automated laboratory, the system allows test results to be achieved more quickly and efficiently than ever before.